<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 1 Issue 4</issue_number>
<issue_period>2010 (October - December)</issue_period>
<title>Synthesis And Evaluation Of Newer Quinoline Derivatives Of Thiazolidinediones For Their Antidiabetic Activity</title>
<abstract>In view of various biological activities of both thiazolidinediones and quinoline derivatives like antidiabetic, antifungal, antitumoral, anti-inflammatory, retinoidal, anti atherosclerotic activities, it was our interest to prepare various thiazolidinedione derivatives with a quinoline ring moiety and to evaluate them for antidiabetic activity. 5-(4-fluorobenzyl)-2,4-thiazolidinedione was synthesized by reaction of 4-fluoroaniline with methyl acrylate to give crude 2-Bromo-3-(4-fluoro-phenyl)-propionic acid methyl ester as an oil which was treated with thiourea in presence of sodium acetate and ethanol to give 5-(4-fluoro-benzyl)-2-imino-thiazolidine-4-one which on oxidation gave 5-(4-fluoro-benzyl)thiazolidine-2,4-dione. This was condensed with the quinoline derivatives in presence of Tetrahydrofuran. Among the synthesized derivatives five of them were screened for oral hypoglycemic activity, the compounds SK, SK-3 were showing significant activity and compound SK2 was showing moderate activity and compounds SK-4 and SK-5 were active. The structures of newly synthesized compounds were established on the basis of elemental analysis, TLC, IR and 1H NMR spectral studies. </abstract>
<authors>L. Srikanth,N. Raghunandan,P. Srinivas,G. Amarender Reddy</authors>
<keywords>Thiazolidinediones, Quinolines, Antidiabetic agents, Chalcones. </keywords>
<pages>120-131</pages>
</article>
</Journal>
